Ezra Cohen to Everolimus
This is a "connection" page, showing publications Ezra Cohen has written about Everolimus.
Connection Strength
0.915
-
Did Everolimus Break the Rules? Clin Cancer Res. 2021 07 15; 27(14):3807-3808.
Score: 0.795
-
A Randomized Multi-institutional Phase II Trial of Everolimus as Adjuvant Therapy in Patients with Locally Advanced Squamous Cell Cancer of the Head and Neck. Clin Cancer Res. 2022 12 01; 28(23):5040-5048.
Score: 0.055
-
Response-adapted volume de-escalation (RAVD) in locally advanced head and neck cancer. Ann Oncol. 2016 05; 27(5):908-13.
Score: 0.035
-
A phase Ib trial of LY2584702 tosylate, a p70 S6 inhibitor, in combination with erlotinib or everolimus in patients with solid tumours. Eur J Cancer. 2014 Mar; 50(5):876-84.
Score: 0.030